Roche's Virtual Pipeline Event

Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema presented at Angiogenesis 2018

On-demand webcast

Link 

Agenda

  • Ophthalmology overview
    Jason Ehrlich, M.D. Ph.D., Senior Group Medical Director, Ophthalmology
  • BOULEVARD: Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema
    Sascha Fauser, M.D., Head pRED Ophthalmology